Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma

International Journal of Cancer - United States
doi 10.1002/ijc.31813
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley